2017-2021 US Infectious Disease Testing Market: Supplier Shares by Test and Market Segment Sales Forecasts

January 2017 | 43 pages | ID: 2F46D7C4BC4EN
Venture Planning Group

Abstracts

This report provides an overview of the US infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.

Contents

BUSINESS ENVIRONMENT

1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
  a. Chronic Illness
  b. Disease Incidence
  c. Susceptibility to Iatrogenesis
  d. Multiple Illness Cases
11. Laboratory Regulations

MARKET STRUCTURE

1. Centralized Testing
  a. Hospitals
  b. Commercial/Private Laboratories
  c. Blood Banks
    1) Community and Regional Centers
    2) Plasma Fractionation Centers
2. Decentralized Testing
  a. Physician Offices/Group Practices
  b. Point of Care Testing
  c. Other Decentralized Testing Locations

MARKET SIZE, GROWTH, AND MAJOR SUPPLIERS’ MARKET SHARES

LIST OF TABLE

Test Volume Forecast by Market Segment
Sales Forecasts by Market Segment
AIDS Testing: Market Shares of Major Suppliers
Chlamydia Testing: Market Shares of Major Suppliers
Gonorrhea Testing: Market Shares of Major Suppliers
Hepatitis Testing: Market Shares of Major Suppliers
Rubella Testing: Market Shares of Major Suppliers
Streptococci Testing: Market Shares of Major Suppliers
Syphilis Testing: Market Shares of Major Suppliers